The view from procurement of their post-COVID world

** Shared Experience – Special Event **

Please join us for this unique, world class procurement group from the US and EMEA large pharma to established Biotech, to hear them discuss the current challenges and opportunities in a new world.  

The main areas of discussion will be:

• What is the immediate impact of Covid 19 on procurement and the organisations they represent?
• What are the practical elements that they have had to put in place to support the new changes?
• How has this affected agency relations, selection and current/future engagements?
• Where does the future lie with regard to HCP communication in all forms and live events/congresses?
• How do they think the industry will look in 12 months time - both in terms of how they operate within and outside their organisations?

Speakers include:

• Malik Akhtar – VP, Marketing Procurement, Bayer
• Karen Fendrich – Senior Director, Global Procurement, Pfizer NYC
• Andrew Kent – Director Rest of World Procurement Gilead Sciences Europe
• Graham Ray – Director, Strategy and Delivery, GSK Procurement CoE